Description
CJC-1295 (No DAC), commonly described as modified GRF(1-29), is a shorter-acting growth hormone-releasing hormone analogue without the Drug Affinity Complex. It is investigated for pulsatile growth-hormone axis signaling. Commercial identity must clearly distinguish it from CJC-1295 with DAC and define the exact sequence, counterion and formulation.
| Mechanism of Action | Primary Research Applications | CAS Number | Molecular Formula | Molecular Weight (g/mol) | IUPAC / Sequence Definition | Material Class | Form / Appearance |
| Combined GHRH receptor and ghrelin receptor agonism | Growth-hormone axis and secretagogue pathway research | Not applicable | Mixture | Modified GRF(1-29) without DAC + Ipamorelin; component ratios must be specified | Blend | White to off-white lyophilized cake/powder |



